Can-Fite BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CANF and other ETFs, options, and stocks.About CANF
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602.
CEOMotti Farbstein
CEOMotti Farbstein
Employees5
Employees5
HeadquartersRamat Gan, HaMerkaz
HeadquartersRamat Gan, HaMerkaz
Founded1994
Founded1994
Employees5
Employees5
CANF Key Statistics
Market cap7.13M
Market cap7.13M
Price-Earnings ratio-0.27
Price-Earnings ratio-0.27
Dividend yield—
Dividend yield—
Average volume412.68K
Average volume412.68K
High today$3.40
High today$3.40
Low today$3.19
Low today$3.19
Open price$3.22
Open price$3.22
Volume32.52K
Volume32.52K
52 Week high$21.00
52 Week high$21.00
52 Week low$2.56
52 Week low$2.56
CANF News
TipRanks 4d
Can-Fite BioPharma Wins Australian Patent Backing Namodenoson in Liver and Pancreatic CancerTipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. R...
TipRanks 4d
Can-Fite BioPharma secures Australian Patent Office allowance for namodenosonCan-Fite BioPharma (CANF) announced that the Australian Patent Office has allowed Patent Application No. 2021290439 entitled “Treatment of Advanced Metastatic C...
CNN 5d
symbol__ Stock Quote Price and Forecast - CNN...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.